Seminar: Accelerating progress on essential medicines with the Lancet Commission and Team Europe

Bridging evidence and action for global health equity

The Lancet Commission: Accelerating Progress on Essential Medicines, in partnership with Team Europe, will convene in Brussels from 9-11 June 2026 for technical deliberations. Building on the 2017 landmark report, the Commission is developing a new report to be launched in 2027: the 50th anniversary of the WHO Model List of Essential Medicines. Supported by Team Europe, this initiative focuses on scaling evidence-based strategies that address systemic barriers in medicine access, with a specific focus on low and middle-income countries.

This is an opportunity to reflect on global concepts of equitable access to health products and transforming research into actionable global policy. Therefore the AU-EU Health Partnership and the Lancet Commission: Accelerating Progress on Essential Medicines are organizing an afternoon to delve into these important topics.

Image

KEY OBJECTIVES

In an era of shifting global health architectures, this event offers a unique platform to:

• Align policy making with preliminary findings: Gain early insights into preliminary findings from The Lancet Commission to inform Team Europe health initiatives strategies.
• Access to medicines and the role of international cooperation: Use scientific evidence to highlight how equitable access to medicines improves global health outcomes, and how international cooperation is essential to achieving this.

TARGET AUDIENCE

This session is designed for an audience with various backgrounds committed to transforming global health systems. While the hybrid format allows for broad participation, the programme is specifically aimed at:

• Policy makers: Representatives from the AU and EU, as well as national policy representatives, looking to align regional strategies with global evidence.
• The AU-EU Health Partnership community: Partners and stakeholders especially within the Manufacturing and Access to Vaccines, Medicines and Health Technologies (MAV+) hub seeking to integrate the Lancet Commission findings into their work.
• Global Health academia: Researchers and thought leaders focused on essential medicines and health equity.
• Development Finance Institutions (DFIs): Stakeholders interested in the intersection of scientific evidence and sustainable investment for health infrastructure.
• Civil society & advocacy leaders: Organizations dedicated to ensuring that technical recommendations translate into tangible improvements in patient access and community health (NGOs, patient organisations, advocacy groups, etc.).

WHY YOU SHOULD ATTEND

• Gain strategic insights through the seminar on preliminary findings of The Lancet Commission: Accelerating Progress on Essential Medicines.
• Shape the Global Health agenda by interacting with global health experts through face-to-face dialogue and structured matchmaking sessions over a working lunch.

AGENDA

• 12h30 – 14h30: Invite-only networking Lunch & structured matchmaking session: AU-EU Health Partnership and Lancet Commissioners
• 14h30 – 16h00: Seminar
• 14h30 – 14h45: Opening and scene-setting 
• 14h45 – 15h30: Panel discussion 
• 15h30 – 15h50: Open discussion
• 15h50 – 16h00: Closing remarks and next steps
• 16h00 – 17h30: Reception

REGISTER

If you would like to join in-person or online, please register your interest.

MORE INFORMATION

For more information on the new Lancet Commission: Accelerating Progress on Essential Medicines: https://essentialmedscommission.org/people/